tiprankstipranks
Biofrontera Initiates Prompt Ameluz® Recall Over Packaging Defects
PremiumCompany AnnouncementsBiofrontera Initiates Prompt Ameluz® Recall Over Packaging Defects
3M ago
Biofrontera FDA Review Advances Ameluz® Dosage Expansion
PremiumCompany Announcements
Biofrontera FDA Review Advances Ameluz® Dosage Expansion
3M ago
Biofrontera announces FDA issued letter regarding sNDA for Ameluz
PremiumThe Fly
Biofrontera announces FDA issued letter regarding sNDA for Ameluz
3M ago
Biofrontera Inc. receives FDA approval for new formulation of Ameluz
PremiumThe FlyBiofrontera Inc. receives FDA approval for new formulation of Ameluz
7M ago
Biofrontera files to sell common stock, no amount given
PremiumThe Fly
Biofrontera files to sell common stock, no amount given
7M ago
Biofrontera Inc. announces results from Phase 1 safety study of BF-200 ALA
PremiumThe Fly
Biofrontera Inc. announces results from Phase 1 safety study of BF-200 ALA
8M ago
Biofrontera Inc. reports preliminary Q2 revenues $5.7M-$5.9M
PremiumThe FlyBiofrontera Inc. reports preliminary Q2 revenues $5.7M-$5.9M
10M ago
Biofrontera Inc. appoints Heikki Lanckriet to board of directors
PremiumThe Fly
Biofrontera Inc. appoints Heikki Lanckriet to board of directors
10M ago
Biofrontera Inc. price target adjusted to $18 at Benchmark after reverse split
PremiumThe Fly
Biofrontera Inc. price target adjusted to $18 at Benchmark after reverse split
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100